Oskar Hoff

Company: Celeris Therapeutics
Job title: Head of Medicinal Chemistry
Seminars:
Data-Driven Design Of Small Molecule Protein Degraders – Utilising Deep Learning To Streamline Drug Development 1:30 pm
Heterobifunctional degraders to hijack E3 ligases Machine learning models leading to ternary complex prediction Synthesis and in vitro screening of selected candidatesRead more
day: Day 2 PM - Stream A